{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:47:19Z","timestamp":1787021239923,"version":"build-2736575974"},"reference-count":43,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100016003","name":"Istanbul University-Cerrahpasa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100016003","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Dopamine agonist (DA)\u2013induced impulse control disorder (ICD) represents a group of behavioral disorders that are increasingly recognized in patients with prolactinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We aimed to examine the genetic component of the underlying mechanism of DA-induced ICD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with prolactinoma receiving dopamine agonist (cabergoline) treatment were included in the study. These patients were divided into 2 groups: patients who developed ICD due to DA and patients who did not. Patients were evaluated for polymorphisms of the DRD1, DRD3, COMT, DDC, GRIN2B, TPH2, OPRK1, OPRM1, SLC6A4, SLC6A3, HTR2A genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 72 patients with prolactinoma using cabergoline, 20 were diagnosed with ICD. When patients with and without ICD were compared according to genotype frequencies, OPRK1\/rs702764, DRD3\/rs6280, HTR2A\/rs6313, SLC6A4\/rs7224199, GRIN2B\/rs7301328, TPH2\/rs7305115, COMT\/rs4680, DRD1\/rs4532 polymorphisms significantly increased in patients with DA-induced ICD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our results show that multiple neurotransmission systems affect DA-induced ICD in patients with prolactinoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgac718","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T20:50:05Z","timestamp":1670619005000},"page":"e275-e282","source":"Crossref","is-referenced-by-count":16,"title":["A Genetic Assessment of Dopamine Agonist-Induced Impulse Control Disorder in Patients With Prolactinoma"],"prefix":"10.1210","volume":"108","author":[{"given":"Serdar","family":"Sahin","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa , Istanbul 34098 , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugce","family":"Sudutan","sequence":"additional","affiliation":[{"name":"Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University , Istanbul 34093 , Turkey"},{"name":"Institute of Health Sciences, Istanbul University , Istanbul 34126 , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasin","family":"Kavla","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa , Istanbul 34098 , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Durcan","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa , Istanbul 34098 , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeliz Yagiz","family":"\u00d6zogul","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa , Istanbul 34098 , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burc Cagri","family":"Poyraz","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa , Istanbul 34098 , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muge","family":"Sayitoglu","sequence":"additional","affiliation":[{"name":"Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University , Istanbul 34093 , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande Mefkure","family":"Ozkaya","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa , Istanbul 34098 , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8329-140X","authenticated-orcid":false,"given":"Pinar","family":"Kadioglu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa , Istanbul 34098 , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,12,10]]},"reference":[{"issue":"1","key":"2023051701091484400_dgac718-B1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11102-005-5079-0","article-title":"The epidemiology of prolactinomas","volume":"8","author":"Ciccarelli","year":"2005","journal-title":"Pituitary"},{"issue":"2","key":"2023051701091484400_dgac718-B2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2023051701091484400_dgac718-B3","author":"Management of hyperprolactinemia"},{"issue":"3","key":"2023051701091484400_dgac718-B4","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1210\/jc.2009-2095","article-title":"Potential cardiac valve effects of dopamine agonists in hyperprolactinemia","volume":"95","author":"Valassi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2023051701091484400_dgac718-B5","author":"Rang","year":"2011","journal-title":"Rang and Dale's Pharmacology"},{"issue":"1","key":"2023051701091484400_dgac718-B6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40264-017-0590-6","article-title":"Dopamine agonists and impulse control disorders: a complex association","volume":"41","author":"Grall-Bronnec","year":"2018","journal-title":"Drug Saf"},{"issue":"Pt 9","key":"2023051701091484400_dgac718-B7","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/brain\/awp170","article-title":"At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists","volume":"132","author":"Abler","year":"2009","journal-title":"Brain"},{"key":"2023051701091484400_dgac718-B8","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","author":"American Psychiatric Association","year":"2013","journal-title":"Diagnostic and Statistical Manual of Mental Disorders"},{"issue":"4","key":"2023051701091484400_dgac718-B9","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00702-012-0934-4","article-title":"Genetics of impulse control disorders in Parkinson's Disease","volume":"120","author":"Cormier","year":"2013","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"2023051701091484400_dgac718-B10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12883-015-0316-2","article-title":"DRD And GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson's disease patients","volume":"15","author":"Zainal Abidin","year":"2015","journal-title":"BMC Neurol"},{"issue":"1","key":"2023051701091484400_dgac718-B11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0893-133X(98)00066-9","article-title":"Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons","volume":"20","author":"Gurevich","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"5544","key":"2023051701091484400_dgac718-B12","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1126\/science.294.5544.980","article-title":"\u201cBehavioral\u201d addictions: do they exist?","volume":"294","author":"Holden","year":"2001","journal-title":"Science"},{"issue":"9","key":"2023051701091484400_dgac718-B13","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1046\/j.1360-0443.1998.93913758.x","article-title":"Familial influences on gambling behavior: an analysis of 3359 twin pairs","volume":"93","author":"Eisen","year":"1998","journal-title":"Addiction"},{"issue":"6","key":"2023051701091484400_dgac718-B14","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/archgenpsychiatry.2010.51","article-title":"Genetic and environmental influences on disordered gambling in men and women","volume":"67","author":"Slutske","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"2023051701091484400_dgac718-B15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/npp.2010.165","article-title":"The roles of dopamine and serotonin in decision making: evidence from pharmacological experiments in humans","volume":"36","author":"Robert","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"2023051701091484400_dgac718-B16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcp.2007.06.043","article-title":"The neurobiology and genetics of impulse control disorders: relationships to drug addictions","volume":"75","author":"Brewer","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"2023051701091484400_dgac718-B17","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1038\/sj.npp.1301565","article-title":"Dopaminergic and glutamatergic regulation of effort- and delay-based decision making","volume":"33","author":"Floresco","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"2023051701091484400_dgac718-B18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pbb.2013.10.018","article-title":"Pharmacogenetics of OPRM1","volume":"123","author":"Crist","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"issue":"12","key":"2023051701091484400_dgac718-B19","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/mds.22678","article-title":"Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease","volume":"24","author":"Lee","year":"2009","journal-title":"Mov Disord"},{"issue":"1","key":"2023051701091484400_dgac718-B20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.parkreldis.2011.08.009","article-title":"Genetic variant of HTR2A associates with risk of impulse control and repetitive behaviors in Parkinson's Disease","volume":"18","author":"Lee","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"2023051701091484400_dgac718-B21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.parkreldis.2011.10.019","article-title":"Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders","volume":"18","author":"Vallelunga","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"2023051701091484400_dgac718-B22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3233\/JPD-130292","article-title":"Genetic susceptibility of impulse control and related behavior in Parkinson's disease","volume":"4","author":"Kim","year":"2014","journal-title":"J Parkinsons Dis"},{"issue":"11","key":"2023051701091484400_dgac718-B23","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1176\/appi.ajp.162.11.2184","article-title":"Impulse control disorders in adult psychiatric inpatients","volume":"162","author":"Grant","year":"2005","journal-title":"Am J Psychiatry"},{"key":"2023051701091484400_dgac718-B24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.psychres.2018.05.006","article-title":"Minnesota impulse disorders interview (MIDI): validation of a structured diagnostic clinical interview for impulse control disorders in an enriched community sample","volume":"265","author":"Chamberlain","year":"2018","journal-title":"Psychiatry Res"},{"issue":"6","key":"2023051701091484400_dgac718-B25","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/cen.12375","article-title":"Impulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case-control study","volume":"80","author":"Bancos","year":"2014","journal-title":"Clin Endocrinol"},{"issue":"6","key":"2023051701091484400_dgac718-B26","first-page":"242","article-title":"Compulsive buying: a report of 20 cases","volume":"55","author":"McElroy","year":"1994","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"2023051701091484400_dgac718-B27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.20045","article-title":"Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome","volume":"19","author":"Evans","year":"2004","journal-title":"Mov Disord"},{"issue":"10","key":"2023051701091484400_dgac718-B28","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/jnnp-2015-312848","article-title":"Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease","volume":"87","author":"Kraemmer","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2023051701091484400_dgac718-B29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.parkreldis.2018.01.010","article-title":"Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants","volume":"49","author":"Castro-Mart\u00ednez","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"issue":"13","key":"2023051701091484400_dgac718-B30","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1021\/bi00013a008","article-title":"Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme","volume":"34","author":"Lotta","year":"1995","journal-title":"Biochemistry"},{"issue":"11","key":"2023051701091484400_dgac718-B31","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nn1583","article-title":"Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction","volume":"8","author":"Kreek","year":"2005","journal-title":"Nat Neurosci"},{"issue":"2","key":"2023051701091484400_dgac718-B32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.eatbeh.2009.01.003","article-title":"Epistatic interaction between COMT and DAT1 genes on eating behavior: a pilot study","volume":"10","author":"Hersrud","year":"2009","journal-title":"Eat Behav"},{"issue":"1-2","key":"2023051701091484400_dgac718-B33","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.psychres.2009.11.026","article-title":"Positive association between GRIN2B gene and bipolar disorder in the Chinese Han population","volume":"185","author":"Zhao","year":"2011","journal-title":"Psychiatry Res"},{"issue":"6","key":"2023051701091484400_dgac718-B34","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1086\/497703","article-title":"Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios","volume":"77","author":"Fallin","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2023051701091484400_dgac718-B35","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neures.2006.06.013","article-title":"Association study of polymorphisms in N-methyl-d-aspartate receptor 2B subunits (GRIN2B) gene with Korean alcoholism","volume":"56","author":"Kim","year":"2006","journal-title":"Neurosci Res"},{"issue":"2","key":"2023051701091484400_dgac718-B36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.mp.4000808","article-title":"Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia","volume":"6","author":"Ohtsuki","year":"2001","journal-title":"Mol Psychiatry"},{"issue":"9","key":"2023051701091484400_dgac718-B37","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/WNL.0000000000000729","article-title":"Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study","volume":"83","author":"Papay","year":"2014","journal-title":"Neurology"},{"key":"2023051701091484400_dgac718-B38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fneur.2018.00109","article-title":"Dopaminergic and opioid pathways associated with impulse control disorders in Parkinson's disease","volume":"9","author":"Erga","year":"2018","journal-title":"Front Neurol"},{"issue":"4","key":"2023051701091484400_dgac718-B39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00008877-199608000-00011","article-title":"Dexfenfluramine and 8-OH-DPAT modulate impulsivity in a delay-of-reward paradigm: implications for a correspondence with alcohol consumption","volume":"7","author":"Poulos","year":"1996","journal-title":"Behav Pharmacol"},{"issue":"3","key":"2023051701091484400_dgac718-B40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s002130000385","article-title":"Effect of central 5-hydroxytryptamine depletion on inter-temporal choice: a quantitative analysis","volume":"149","author":"Mobini","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"2023051701091484400_dgac718-B41","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s002130050121","article-title":"The pharmacology of impulsive behaviour in rats: the effects of drugs on response choice with varying delays of reinforcement","volume":"128","author":"Evenden","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"issue":"7","key":"2023051701091484400_dgac718-B42","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.55.7.593","article-title":"A tryptophan hydroxylase gene marker for suicidality and alcoholism","volume":"55","author":"Nielsen","year":"1998","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"2023051701091484400_dgac718-B43","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/npp.2009.216","article-title":"Risk-taking behavior in a gambling task associated with variations in the tryptophan hydroxylase 2 gene: relevance to psychiatric disorders","volume":"35","author":"Juhasz","year":"2010","journal-title":"Neuropsychopharmacology"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgac718\/48479319\/dgac718.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/6\/e275\/50355228\/dgac718.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/6\/e275\/50355228\/dgac718.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T21:12:03Z","timestamp":1684271523000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/6\/e275\/6886515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,10]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,12,10]]},"published-print":{"date-parts":[[2023,5,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgac718","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,6]]},"published":{"date-parts":[[2022,12,10]]}}}